Researchers at Siriraj Hospital, part of Mahidol University, claim they have developed the world’s first “antibody treatment” that could cure Ebola virus infections.
At least a year away from practical application, the antibody was called a significant step toward finding a cure for the disease, which has killed more than 3,000 people in West Africa this year. Currently there is no cure, although several experimental drugs have been deployed in the battle against the epidemic.
Meanwhile, the World Health Organisation said Wednesday it has at least 1,500 doses of an experimental vaccine ready to be given to medical personnel fighting the disease in Africa. The German Press Agency said WHO has been working to speed up testing of two experimental-stage vaccines – chimpanzee adenovirus developed by British company GlaxoSmithKline and a US government laboratory, and VSV developed by Canada’s health agency.
Siriraj’s antibody – developed with the use of human genes, not the Ebola virus itself – is small enough to enter infected cells and access virus proteins within them, doctors said. The antibody is five times smaller than what is being tested in the United States, said Dr Udom Kachinthorn, dean of the medical science faculty at Siriraj.
He said the Thai antibody had different structures and mechanisms and was more efficient, making a cure derived from it more effective.
Researchers used synthesised Ebola genes in development of the antibody and tested them on samples of haemorrhagic-fever viruses similar, but less virulent, than the five Ebola variants.
Thailand does not possess a Biosafety Level 4 facility required to test on the Ebola virus itself. Doctors also admitted they have not been in contact with the World Health Organisation regarding the purported cure.
The next step will be to conduct testing on animals before moving on to human trials. If the tests are successful, the antibody would then need to be mass produced. That step would be at least a year away, Dr Udom cautioned.
However, he added, the Thai pharmaceutical sector could expedite the drug’s development, pending more tests. To facilitate that, Siam Bioscience, a joint Thai-Cuban pharmaceutical venture launched this year, will join in the research.
Doctors, eager to promote the antibody treatment as the first of its kind developed in Thailand, emphasised it is not a vaccine. Dr Wanpen Chaicumpa, head of the Ebola antibody-development team, said the treatment would be administered after infection through injection.
The Latest on: Ebola cure
via Google News
The Latest on: Ebola cure
- Is This Coronavirus Treatment Setting Investors Up for Failure?on November 27, 2020 at 3:30 am
Its early use as a treatment against COVID-19 made sense, because the drug had previously shown an ability to stunt coronavirus replication. Subsequent clinical trial results have been controversial.
- Seasoned by work with Ebola and HIV, UNC doctor becomes a leading voice on coronavirus | Raleigh News & Observeron November 26, 2020 at 10:28 pm
Dr. David Wohl, a UNC infectious disease specialist, is helping with efforts to slow the spread of the coronavirus and to find vaccines and treatments.
- Arca Biopharma gets fast-track approval from FDA for potential Covid-19 treatmenton November 24, 2020 at 10:05 am
The fast track designation helps expedite Arca's process of investigating one of its drugs as a potential Covid-19 treatment.
- Ebola virus disease – Democratic Republic of the Congoon November 19, 2020 at 7:29 am
On 18 November 2020, the Minister of Health of the Democratic Republic of the Congo declared the end of the Ebola Virus Disease (EVD) outbreak in Equateur Province.
- Remdesivir May Keep Ebola Out of the Bedroomon November 19, 2020 at 5:30 am
Remdesivir (Veklury) was originally developed as a treatment for Ebola virus infection and, despite having failed in an earlier trial, may now have found its niche there. In a phase II study conducted ...
- Democratic Republic of the Congo declares the end to its 11th Ebola outbreakon November 18, 2020 at 10:14 pm
The Democratic Republic of Congo (DRC) officially declared the end of its 11th Ebola outbreak Wednesday, six months after the first cases of the deadly virus were reported.
- Congo declares end of Ebola outbreak, sees lessons for COVID fighton November 18, 2020 at 10:32 am
Democratic Republic of Congo announced the end of an almost six-month Ebola outbreak in the west of the country on Wednesday as health authorities looked to apply lessons from the successful response ...
- UNICEF welcomes end of Ebola outbreak in the Equateur Province of the DRCon November 18, 2020 at 6:45 am
English News and Press Release on Democratic Republic of the Congo about Health, Recovery and Reconstruction, Epidemic and more; published on 18 Nov 2020 by UNICEF ...
- Congo declares end of Ebola outbreak that killed 55on November 18, 2020 at 5:16 am
Democratic Republic of Congo's health minister on Wednesday announced the end of an Ebola outbreak in the west of the country that infected 130 people and killed 55.
- Defeating Ebola in the Democratic Republic of the Congoon November 17, 2020 at 8:38 pm
Jeudi Mputu felt unwell. He went for a check-up at an Ebola treatment centre where he tested positive for the virus. However, his visit was short-lived. He fled the facility. A few days later he was ...
via Bing News